Fountain Therapeutics, Inc. is a California-based biotechnology holding company focused on developing therapeutics that target cellular rejuvenation and reverse aging mechanisms.
Subscribe to see Fountain Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Fountain Therapeutics, Inc. is a company headquartered in South San Francisco, United States. Its most recent funding round, Series A, raised $15M in June 2026. Xcout tracks 5 named people at Fountain Therapeutics, Inc., including Simon Tsang (Chief Business Officer).
As of 16 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $15M | 5 named | |
| SEC Form D filing | $15.9M | — | |
| Series A | $6M | 2 named | |
| SEC Form D filing | $5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A funding-flow diagram of the 6 named investors across 2 rounds: who backed which round, who led it, and who came back for the next one.
Sign in to see it, or subscribe for the full funding history →
A few of Fountain Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Relation Therapeutics Inc. is an active for-profit biotechnology company founded in 2019 that focuses on therapeutic development.
Gero is a biotechnology company headquartered in Singapore with a U.S. subsidiary, combining physics, biology, and artificial intelligence to decode human biology and develop life-changing medicines.
EonArk is an AI-bio company building an artificial intelligence platform for longevity science and anti-aging drug discovery using cross-species data. The company develops interpretable machine learning systems to identify aging characteristics, model regulatory network nodes, and validate hypotheses through experimental wet-lab workflows. Additionally, EonArk offers precision health services utilizing methylation testing to assess biological age and health status as an early commercial entry point.
Standard Model Biomedicine is a biotechnology research company based in San Francisco, United States. The company is focused on developing a foundation model for human biology to advance biomedical research.
Juvena Therapeutics, Inc. is a computationally-driven biopharmaceutical company operating in the biotechnology and biopharma industry, headquartered in Redwood City, California.
Cellarity is a U.S. biotechnology company that uses single-cell biology, computational modeling, and machine learning to discover medicines based on cellular behaviors and disease mechanisms. It serves pharmaceutical and biotechnology development needs, advancing its own therapeutic programs and potentially partnering with other drug developers.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Fountain Therapeutics, Inc.? Suggest a correction · Work at Fountain Therapeutics, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.